Progress in systemic chemotherapy of primary breast cancer: an overview.

Journal of the National Cancer Institute. Monographs

Volumn , Issue 30, 2001, Pages 72-79

  Hortobagyi, G N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BRIDGED COMPOUND; HORMONE; TAXANE; TAXOID;

ADJUVANT CHEMOTHERAPY; BREAST TUMOR; DRUG POTENTIATION; HUMAN; METHODOLOGY; PATHOLOGY; REVIEW; TIME; TREATMENT OUTCOME; UTILIZATION REVIEW;

ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; BRIDGED COMPOUNDS; CHEMOTHERAPY, ADJUVANT; DRUG SYNERGISM; HORMONES; HUMANS; TAXOIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035747528     PISSN: 10526773     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jncimonographs.a003465     Document Type: Review

References (107)